Don't see how management is bad. Management successfully brought Cabo through FDA trials and to FDA approval. EMEA approval and further worldwide approval will follow suit as will other cancer indications. Look at the pipeline both actively recruiting and soon to be recruiting. The list grows and grows. The stock market cap is under $1B. Compare that to Medivation and PCYC which are $5B. Exelixis will be a $5B market cap company and more. The revenues that are starting to come in are just the tip of the ice berg. The company is hiring and sees a lot of growth. Apple, Inc did the same many years ago. Hiring was an indication of further sales and growth. The company management of Exelixis are not stupid.
Moreover, Exel has partnered with Genentech and Genentech certainly knows how to create effective cancer drugs.
You sure are sounding as though Mike ripped out your scrotum and is about to stick it in your mouth. You are what I call a Crying SOB without a life. You have been here for a long time now, obviously your bashing hasn't done any good .